Lungpacer® | Temporary Transvenous Diaphragm Neurostimulation
The AeroPace® System uses temporary transvenous diaphragm neurostimulation to activate the diaphragm, accelerate ventilator weaning, and restore independent breathing.
Overview
Lungpacer Medical is a privately held medical device company focused on respiratory and critical care medicine, headquartered in Vancouver, BC. The company designs non-surgical, minimally invasive technologies to improve patient ventilation. Its primary product, the Lungpacer Diaphragm Pacing Therapy System™, is a temporary transvenous diaphragmatic neurostimulation system that has received FDA Emergency Use Authorization for use during the COVID-19 pandemic. This system utilizes the Lungpacer IntraVenous Electrode - LIVE Catheter® to stimulate the diaphragm through a central venous catheter, which is similar to catheters used in mechanically ventilated ICU patients. The device aims to strengthen a weakened diaphragm affected by ventilator-induced diaphragm dysfunction (VIDD), potentially aiding in faster weaning from mechanical ventilation. The Lungpacer DPTS is authorized for emergency use only during the current public health emergency.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Vancouver, BC
- Type
- Privately Held
- Founded
- 2009
- Followers
- 4,072
- Specialties
- Respiratory Care and Medical Device
- Locations
- 601 W Cordova Street Suite 130 Vancouver, BC V6B1G1, CA
260 Sierra Drive Suite 116 Exton, PA 19341, US